Deletions and/or loss-of-function mutations in SETD2 are also detected recurrently in different types of leukemia and solid tumors including gastroesophageal cancers and lung adenocarcinoma (LUAD), though at lower frequency than seen in ccRCC (10, 20–23). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.